Tempus AI Acquires Personalis in $1.5 Billion Deal; Stocks Tumble
Tempus AI's $1.5 billion purchase of Personalis triggers a sell-off in shares of both companies despite strategic interest in cancer diagnostics. Tempus AI agreed to acquire cancer diagnostics firm Personalis for $1.5 billion, aiming to bolster its portfolio in tumor DNA s